CD8A and neoplasm: A study by Martins et al. evaluated samples from 21 patients receiving treatment with concurrent chemoradiation and found that patients who responded to therapy had a more inflammatory tumor microenvironment, designated by higher numbers of CD8+ TILs compared to non-responders [133].